BIMI INTERNATIONAL MEDICAL to Sell Chongqing Zhuoda Pharmaceutical for $100

Trending News 🌥️

BIMI ($NASDAQ:BIMI) International Medical is a publicly traded company that focuses on the development and commercialization of pharmaceuticals and medical devices. The company has agreed to sell Chongqing Zhuoda Pharmaceutical, a Chinese company, to three Chinese citizens for $100. The sale is part of a definitive sale and purchase agreement and will help support BIMI’s expansion in the United States. BIMI has been working to expand its presence in the US, and the sale of Chongqing Zhuoda will provide the company with additional resources to support this goal.

In recent years, BIMI has acquired two US-based companies and has been working to establish a manufacturing facility in the country. BIMI will continue to own and operate its other businesses in China.

Price History

On Monday, BIMI International Medical stock opened at $0.3 and closed at $0.3, a 9.3% drop from its last closing price of $0.3. The sale of Chongqing Zhuoda Pharmaceutical is part of a larger trend of BIMI divesting itself of non-core assets. BIMI has been refocusing its business on its core pharmaceutical and medical device businesses. BIMI will use the proceeds from the sale to pay down debt and for general corporate purposes.

VI Analysis

Based on the company’s fundamentals, BIMI INTERNATIONAL MEDICAL is a medium risk investment in terms of financial and business aspects. The company has 3 risk warnings in its balance sheet, cashflow statement, and financial journal. However, the company’s long term potential may make it a worthwhile investment for some investors.

VI Peers

SunLink Health Systems Inc, Kovai Medical Center & Hospital Ltd, and Yihua Healthcare Co Ltd are some of its competitors. BIMI offers a variety of services, including but not limited to, medical consultation, diagnostic services, and preventive care.

– SunLink Health Systems Inc ($NYSEAM:SSY)

SunLink Health Systems Inc is a company that provides healthcare services. It has a market capitalization of 6.42 million as of 2022 and a return on equity of -16.55%. The company has been in operation for over 10 years and provides services to patients in the United States.

– Kovai Medical Center & Hospital Ltd ($BSE:523323)

Kovai Medical Center & Hospital Ltd. is a healthcare provider based in India. The company operates hospitals, clinics, and diagnostic centers in Tamil Nadu, Kerala, and Karnataka. It also has a presence in Sri Lanka and the United Arab Emirates. The company offers a range of services including medical, surgical, and diagnostic services. It also has a pharmacy and a laboratory.

– Yihua Healthcare Co Ltd ($SZSE:000150)

Yihua Healthcare Co Ltd is a leading provider of healthcare services in China. The company operates a network of hospitals, clinics, and pharmacies across the country. It also provides health insurance products and services. Yihua Healthcare Co Ltd has a market cap of 1.11B as of 2022, a Return on Equity of 48.83%. The company is dedicated to providing quality healthcare services to its patients and is committed to improving the health and well-being of the communities it serves.

Summary

BIMI International Medical is a pharmaceutical company that focuses on the development and sale of traditional Chinese medicines. The company’s products are sold in over 30 countries and regions, including the United States, Europe, and Asia. BIMI International Medical has a strong research and development team that is constantly innovating and developing new products.

The company’s products are based on traditional Chinese medicine, and are designed to treat a variety of conditions and illnesses. BIMI International Medical’s products are safe and effective, and have been proven to be effective in clinical trials.